TransMedics Receives FDA Premarket Approval for OCS™ DCD Heart Indication
TransMedics Group, Inc. (NASDAQ: TMDX) received premarket approval (PMA) from U.S. Food and Drug Administration (FDA) for its OCS™ Heart System in favour of use with organs from donors after circulatory death (DCD).
Benzinga ·